Impact Biomedical Inc (IBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBO | AZN | AMGN | GILD | BMY |
| Company | Impact Biomedical Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.5794 | 199.78 | 352.72 | 139.61 | 60.23 |
| High | 0.6097 | 204.34 | 354.16 | 141.34 | 60.58 |
| Low | 0.5550 | 199.23 | 348.39 | 139.26 | 59.84 |
| Latest | 0.6097 | 202.74 | 350.11 | 140.01 | 59.53 |
| Change | -0.0041 | +2.01 | -3.17 | -0.29 | -1.57 |
| % Change | -0.67% | +1.00% | -0.90% | -0.21% | -2.57% |
| Volume | 33,535 | 809,760 | 392,754 | 1,220,407 | 3,690,762 |
| 20-Day Average Volume | 1,066,251 | 1,769,184 | 2,608,035 | 5,956,895 | 13,189,739 |
| Previous Close | 0.6138 | 200.73 | 353.28 | 140.30 | 61.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5727 | 191.44 | 358.48 | 141.29 | 59.34 |
| 20-Day Raw Stochastic | 50.43% | 98.91% | 18.22% | 42.06% | 62.16% |
| 20-Day Relative Strength | 54.73 | 60.53 | 45.16 | 48.83 | 53.26 |
| Weighted Alpha | -68.61 | +50.54 | +21.43 | +32.36 | +18.85 |
| Today's Opinion | 56% Buy | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Previous Opinion | 56% Buy | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.62% since 03/26/26 | +11.28% since 03/26/26 | -0.51% since 03/26/26 | +2.58% since 03/26/26 | +1.03% since 03/26/26 |
| Low | 0.5270 on 03/27/26 | 187.95 on 03/27/26 | 347.11 on 03/31/26 | 133.89 on 03/30/26 | 58.37 on 03/27/26 |
| High | 0.6142 on 03/31/26 | 204.32 on 04/02/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +50.22% since 03/02/26 | +0.17% since 03/02/26 | -8.90% since 03/02/26 | -6.42% since 03/02/26 | -3.69% since 03/02/26 |
| Low | 0.4000 on 03/04/26 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 0.8300 on 03/05/26 | 204.32 on 04/02/26 | 381.74 on 03/03/26 | 149.38 on 03/10/26 | 62.58 on 03/04/26 |
| 3-Month | |||||
| %Chg | +16.12% since 01/02/26 | +11.43% since 01/02/26 | +7.24% since 01/02/26 | +15.46% since 01/02/26 | +12.31% since 01/02/26 |
| Low | 0.3700 on 02/17/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 0.8300 on 03/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -6.59% since 10/02/25 | +21.98% since 10/02/25 | +18.14% since 10/02/25 | +26.99% since 10/02/25 | +31.29% since 10/02/25 |
| Low | 0.3700 on 02/17/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 109.66 on 10/03/25 | 42.52 on 10/29/25 |
| High | 0.8300 on 03/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 64,216 | 311,313,728 | 190,441,936 | 174,143,456 | 126,036,304 |
| Shares Outstanding, K | 104,621 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 30,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -11,840,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 10,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 5,250,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 3.81 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 11/07/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/13/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.53 | 16.10 | 17.10 | 9.86 |